Modelling the process of drug resistance
- 31 March 1994
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 10, S91-S96
- https://doi.org/10.1016/0169-5002(94)91671-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.Journal of Clinical Oncology, 1992
- Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1991
- Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.Journal of Clinical Oncology, 1990
- Resistance to Drugs Associated With the Multidrug Resistance Phenotype Following Selection With High-Concentration MethotrexateJNCI Journal of the National Cancer Institute, 1989
- Multidrug Resistance: Molecular Biology Clinical RelevanceJNCI Journal of the National Cancer Institute, 1989
- Coinduction of MDR-1 Multidrug-Resistance and Cytochrome P-450 Genes in Rat Liver by XenobioticsJNCI Journal of the National Cancer Institute, 1988
- Multidrug Resistance1JNCI Journal of the National Cancer Institute, 1988
- MUTATIONS OF BACTERIA FROM VIRUS SENSITIVITY TO VIRUS RESISTANCEGenetics, 1943